Medical Research
(H123)
IRS Verified
DX Registered
990 on File
PAULA TAKACS FOUNDATION FOR SARCOMA RESEARCH
Financial strength (30%)
67/100
Reliability (20%)
50/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The Paula Takacs Foundation funds novel clinical trials and other sarcoma research projects at Levine Cancer Institute and Levine Children’s Hospital in Charlotte, NC to help elevate global hope for cures. We also seek to amplify awareness, striving to speed diagnoses and save lives.
Financial Overview — FY 2025
$676K
Total Revenue
$561K
Total Expenses
$887K
Net Assets
2
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
96.6%
Fundraising Efficiency
N/A
Operating Reserve
18.96x
Liability-to-Asset
2.2%
Revenue Diversification
98.7%
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
96.6% | 84.6% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
2.6% | 10.0% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.8% | 0.0% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
19.0 mo | 11.7 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.2% | 0.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.7% | 92.2% |
P10P90
|
Below median |
|
Surplus margin
Surplus as a share of revenue
|
16.9% | -1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $676K | $561K | $887K | 96.6% | 2 |
| 2023 | $579K | $440K | $716K | 97.3% | 2 |
| 2022 | $617K | $391K | $577K | 97.8% | 1 |
| 2021 | $369K | $328K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.